Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Desch

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Current Opinion in Oncology|March 1, 1996
Economic considerations in the care of lung cancer patientsC E Desch, B E Hillner, T J Smith
Journal of Hematotherapy|January 1, 1993
Principles of cost effectiveness analysis for the assessment of current and new therapiesB E Hillner, T J Smith, C E Desch
JAMA|April 15, 1992
Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial resultsB E Hillner, T J Smith, C E Desch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer careB E Hillner, T J Smith, C E Desch
Blood|May 15, 1990
Tumor necrosis factor-alpha exhibits greater proinflammatory activity than lymphotoxin in vitroC E Desch, A Dobrina, B B Aggarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysisB E Hillner, J C Weeks, C E Desch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapseC E Desch, M R Lasala, T J Smith, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1991
Teaching specialty cancer medicine in rural hospitals: the cancer outreach program as a modelT J Smith, C E Desch, C J Simonson, et al.
Journal of Palliative Care|April 1, 1997
How long does it take to get a "do not resuscitate" order?T J Smith, C E Desch, M H Hackney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomesC E Desch, B E Hillner, T J Smith, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Current Opinion in Oncology|March 1, 1996
Economic considerations in the care of lung cancer patientsC E Desch, B E Hillner, T J Smith
Journal of Hematotherapy|January 1, 1993
Principles of cost effectiveness analysis for the assessment of current and new therapiesB E Hillner, T J Smith, C E Desch
JAMA|April 15, 1992
Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial resultsB E Hillner, T J Smith, C E Desch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer careB E Hillner, T J Smith, C E Desch
Blood|May 15, 1990
Tumor necrosis factor-alpha exhibits greater proinflammatory activity than lymphotoxin in vitroC E Desch, A Dobrina, B B Aggarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysisB E Hillner, J C Weeks, C E Desch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapseC E Desch, M R Lasala, T J Smith, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1991
Teaching specialty cancer medicine in rural hospitals: the cancer outreach program as a modelT J Smith, C E Desch, C J Simonson, et al.
Journal of Palliative Care|April 1, 1997
How long does it take to get a "do not resuscitate" order?T J Smith, C E Desch, M H Hackney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomesC E Desch, B E Hillner, T J Smith, et al.
Pageof 5